Clinical Trial Update: Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating whether nutritional supplementation with Product 4808 affects acute skeletal muscle protein synthesis in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Product 4808

Snippet

Sponsor: University of Arkansas | Conditions: Cancer | NA | Status: COMPLETED